Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components

Transfusion

Volumn 38, Issue 10, 1998, Pages 966-974

  Adams, M R ^a   Dumont, L J ^b   McCall, M ^b   Heaton, W A ^a,c  

^a Blood Centers of the Pacific   (United States)

^b Gambro BCT   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

EID: 0031713243     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.381098440862.x     Document Type: Article

References (30)

1. Heddle N. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies. Transfus Med Rev 1994;8:15-28.
2. Saarinen UM, Koskimies S, Myllyla G. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer. Vox Sang 1993;65:286-92.
3. Bordin JO, Bardossy L, Blajchman MA. Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization. Transfusion 1993;33:798-801.
4. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
5. Muylle L, Wouters E, Peetermans ME. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-90.
6. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
7. De Witte T, Schattenberg A, Van Dijk BA, et al. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood components from cytomegalovirus-unscreened blood-bank donors. Transplantation 1990;50:964-8.
8. Bowden R, Slichter S, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood components for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
9. Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992;80:2128-35.
10. Shibata R, Siemon C, Rizvi TA, et al. Reactivation of HIV type 1 in chronically infected chimpanzees following xenostimulation with human cells or with pulses of corticosteroid. AIDS Res Hum Retroviruses 1997;13:377-81.
11. Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest 1995;24:311-7.
12. Dzik S, Blajchman MA, Blumberg N, et al. Current research on the immunomodulatory effect of allogeneic blood transfusion. Vox Sang 1996;70:187-94.
13. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997;37:487-92.
14. Dumont LJ, Dzik WH, Rebulla P, Brandwein H. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion 1996;36:11-20.
15. Dumont LJ, Dumont DF. Enhanced flow cytometric method for counting very low numbers of white cells in platelet components. Cytometry (Communications in Clinical Cytometry) 1996;26:311-6.
16. Kunicki T, Tuccelli M, Becker G, Aster R. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975;15:414-21.
17. Holme S, Vaidja K, Murphy S. Platelet storage at 22 degrees C: effect of type of agitation on morphology, viability, and function in vitro. Blood 1978;52:425-35.
18. Holme S, Holsen H. ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet rich plasma. Scand J Haematol 1975;15:96-103.
19. Fijnheer R, Modderman P, Veldman H, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Transfusion 1990;30:20-5.
20. Armitage W. The effects of osmotic stress on human platelets. J Cell Physiol 1985;123:241-8.
21. Feinman R, Detwiler T, Ingerman-Wojenski C. The lumiaggregometer as a research and clinical tool. In: Longnecker GL, ed. The platelets: physiology and pharmacology. Orlando: Academic Press, 1985:429-40.
22. Diem K, Seldrup J. Geigy scientific tables, vol 2. Introduction to statistics, statistical tables, mathematical formulae. Basel: Ciba-Geigy, 1982:52-3.
23. Snyder E, Stack G, Napychank P, Roberts S. Storage of pooled platelet concentrates: in vitro and in vivo analysis. Transfusion 1989;29:390-5.
24. Guideline on general principles of process validation. Center for Drugs and Biologics and Center for Devices and Radiological Health, Division of Manufacturing and Components Quality (HFN-320). Rockville, MD: Food and Drug Administration, 1995:17-61-17-72.
25. Kao KJ, Mickel M, Braine HG, et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The TRAP Study Group. Transfusion 1995;35:13-9.
26. Blajchman MA, Bardossy L, Carmen RA, et al. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blood 1992;79:1371-5.
27. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7.
28. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
29. Takahashi T, Abe H, Nakai K, Sekiguchi S. Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter (letter). Transfusion 1995;35:967.
30. Colman RW, Scott CF, Brandwein H, Whitbread J. More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters (letter). Transfusion 1996;36:939-40.